Cargando…
Regadenoson myocardial perfusion scintigraphy for the evaluation of coronary artery disease in patients with lung disease: A series of five cases
Coronary artery disease (CAD) is a leading cause of death and morbidity globally. Myocardial perfusion scintigraphy (MPS) is commonly used for the diagnosis of CAD, necessitating hyperaemia achieved either by physical exertion or by pharmacological stress, most commonly through use of a coronary art...
Autores principales: | Reyes, Eliana, Richard Underwood, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031215/ https://www.ncbi.nlm.nih.gov/pubmed/31797320 http://dx.doi.org/10.1007/s12350-019-01956-w |
Ejemplares similares
-
Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013) -
Left ventricular ischemia after arterial switch procedure: Role of myocardial perfusion scintigraphy and cardiac CT
por: Bernsen, Marie Louise E., et al.
Publicado: (2019) -
Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
por: Kero, Tanja, et al.
Publicado: (2021) -
Myocardial ischaemic burden assessed by three-dimensional perfusion CMR - comparison with Myocardial Perfusion Scintigraphy
por: Jogiya, Roy, et al.
Publicado: (2013) -
Diagnostic performance of regadenoson stress CMR for detection of coronary artery disease
por: Patel, Mita, et al.
Publicado: (2015)